02/10/2017 - 15/10/2017.

Cancer Research UK, £49,061, ICS - CLINICAL TRIALS RESEARCH, Professor A Chalmers (PI), MVLS ICS - CLINICAL TRIALS UNIT GARSCUBE, Dr M Gomez-Roman, Combining Akt inhibitor MK-2206 with radiation to improve outcomes for glioblastoma

Diabetes UK, £0, IHW - ROBERTSON CENTRE, Professor I Ford, MVLS MED -HUMAN NUTRITION, Professor ME Lean (PI), RI CARDIOVASCULAR & MEDICAL SCIENCES, Professor NA Sattar, Reversal of T2DM to normal glucose tolerance using non-surgical weight management with low-energy liquid- diet and long-term maintenance, within routine NHS care: study extension

Engineering & Physical Sciences Research Council, £60,000, CHEM - CHEMISTRY, Professor M Kadodwala, ENG - BIOMEDICAL ENGINEERING, Professor N Gadegaard, SCHOOL OF CHEMISTRY, Dr AS Karimullah (PI), Imaging Plasmonic Polarimetry for Biomolecular Characterisation

Medical Research Council, £30,941, IHW - MENTAL HEALTH & WELLBEING, Professor JJ Evans, MVLS MED - ANAESTHESIA, Dr T Quasim, RI CARDIOVASCULAR & MEDICAL SCIENCES, Professor DJ Stott (PI), MICA: Development of a software application for detection and monitoring of                                 

Muscular Dystrophy UK, £57,620, RI MOLECULAR CELL & SYSTEMS BIOLOGY, Professor DG Monckton (PI), Cis- and trans-genetic modifiers of myotonic dystrophy type 1

National Cancer Research Institute, £74,212, ICS - EXPERIMENTAL THERAPEUTICS, Dr KA Oien (PI), Chair of CM-Path

Scottish Government - Health and Social Care Integration Dir, £100,000, IHW - MENTAL HEALTH & WELLBEING, Professor S Cooper (PI), Dr D Kinnear, Learning disabilities - The Scottish Learning Disabilities Observatory

The Beatson Institute for Cancer Research, £53,532, ICS - BEATSON INSTITUTE FOR CANCER RES., Professor JC Norman (PI), Glasgow Cancer Centre Clinical Research Fellowship 2016/2017

UK Children's Cancer Study Group, £99,993, ICS - BEATSON INSTITUTE FOR CANCER RES., Professor E Gottlieb, ICS - EXPERIMENTAL THERAPEUTICS, Dr F Thomson, RI CANCER SCIENCES, Dr C Halsey (PI), Developing Leukaemic Biomarkers to Enable Personalised CNS-directed Therapy